Green book 3 Flashcards Preview

Question Bank > Green book 3 > Flashcards

Flashcards in Green book 3 Deck (52)
Loading flashcards...
1
Q

Which of the following statements is/are true regarding Hepatitis B infection:

a) Infection results in jaundice in greater than 50% of all cases
b) The incubation period ranges from 14-60 days
c) Chronic disease is strongly linked to the development of liver cancer
d) Less that half of children infected per-natally develop chronic disease
e) Most of those infected as adults will become chronic carriers of HBV

A

Chronic disease is strongly linked to the development of liver cancer

2
Q

Hepatitis B vaccines:

a) Are not effective in patients with acute hepatitis B
b) Are live attenuated vaccines
c) Fewer than 10% of adults fail to respond to hep B vaccines adequately
d) Are very effective if used for post-exposure prophylaxis
e) Work best in those aged over 40 years

A

Are not effective in patients with acute hepatitis B

Fewer than 10% of adults fail to respond to hep B vaccines adequately

Are very effective if used for post-exposure prophylaxis

3
Q

Hepatitis B vaccines:
a) Contain hepatitis B core antigen prepared from yeast cells
b) All contain the same dosage
c) Should not be given to a person who may already have been exposed to Hepatitis B
without checking for markers of past infection
d) Should not be administered into the buttock
e) Induce anti-HBs specific antibodies

A

Are interchangeable (different vaccines can be used to complete a primary course)

Should not be administered into the buttock

Induce anti-HBs specific antibodies

4
Q

Which of the following people should receive pre-exposure Hepatitis B vaccine:

a) Healthcare workers (including students/trainees) working in the UK
b) Staff working in residential accommodation for people with learning difficulties
c) Embalmers
d) Prison officers
e) Laboratory staff handling materials which may contain the virus

A

Healthcare workers (including students/trainees) working in the UK

Staff work at residential accommodation for people with learning difficulties

Embalmers

Prison officers

Laboratory staff handling materials which may contain the virus

5
Q

Which of the following should receive pre-exposure Hepatitis B vaccine:

a) Short term foster carers
b) Sewage workers
c) People receiving regular blood transfusions
d) People with chronic liver disease
e) People with chronic renal disease

A

Short term foster carers

People receiving regular blood transfusions

People with chronic liver disease

People with chronic renal disease

6
Q

Which of the following should receive pre-exposure Hepatitis B vaccine:

a) People living in residential accommodation with learning disabilities
b) Prison inmates
c) Intra-venous drug users
d) Household contacts of people who inject drugs
e) People who work with primates

A

People living in residential accommodation with learning disabilities

Prison in mates

Intravenous drug users

Household contacts of people who inject drugs

7
Q

Post-exposure prophylaxis with HBIG is recommended for:
a) Non-responders to hep B vaccine who have had a needle stick injury from a patient
with acute hepatitis B
b) People who have had unprotected sexual intercourse with a case of acute of
hepatitis B seen within one week of last contact
c) Babies born to women with chronic hepatitis B infection who are e antigen positive
d) People who have had unprotected sexual intercourse with a recently diagnosed case
of chronic hepatitis B 2 weeks ago
e) Babies born to women who have developed acute hepatitis B infection during
pregnancy

A

Non-responders to hep B vaccine who have had a needle stick injury from a patient with acute hepatitis B

People who have had unprotected sexual intercourse with a case of acute of hepatitis B seen within one week of last contact

Babies born to women with chronic hepatitis B infection who are e antigen positive

Babies born to women who have developed acute hepatitis B infection during pregnancy

8
Q
Available pre-exposure hepatitis B immunisation schedules for high risk
exposure in adults include:
a) 0, 1 month, 2 months and 12 months
b) 0, 7 days, 21 days and 12 months
c) 0, 1 month, 6 months and 12 months
d) 0, 2 months, 6 months and 12 months
e) 0, 2 months, 3 months and 4 months
A

0, 1 month, 2 months and 12 months

0, 7 days, 21 days and 12 months

9
Q

An immunocompetent healthcare worker is found to have an anti-HBs level of 10
– 100 mIU/ml after a course of hepatitis B vaccine. Which of the following is/are
true?
a) They need no further doses of hep B vaccine as satisfactory protection has been
achieved
b) They should have 1 further dose of hep B vaccine
c) They should have 1 further course of hep B vaccine
d) They should have single booster dose of hep B vaccine after 5 years
e) They should receive a booster dose of hep B vaccine every 5 years

A

They should have 1 further dose of hep B vaccine

They should have single booster dose of hep B vaccine after 5 years

10
Q

The following is/are true of babies born to hep B positive mothers:
a) If the mother is HBsAg positive and HBeAg the baby should receive a dose of HBIG
at birth
b) If the mother is HBsAg positive, HBeAg negative and the baby weighs 1800g the
baby should receive HBIG
c) The first dose of hep B vaccine should be given within 24 hours of birth
d) They should be tested for HBsAg at 6 months of age
e) They should be tested for HBsAg at 12 months of age

A

If the mother is HBsAg positive and HBeAg the baby should receive a dose of HBIG at birth

The first dose of hep B vaccine should be given within 24 hours of birth

They should be tested for HBsAg at 12 months of age

11
Q

Babies born after the 1st August 2017 in the UK whose mothers are NOT known to
be hep B carriers should receive:
a) Three doses of Hexavalent vaccine at 8, 12 and 16 weeks
b) A booster dose of Hexavalent vaccine at 1 year
c) A blood test for HBsAg at 1 year
d) A pre-school booster dose of Hexavalent vaccine
e) A blood test to measure response to the hep B vaccine 2 months after completion of
the Hexavalent vaccine schedule

A

Three doses of Hexavalent vaccine at 8, 12 and 16 weeks

A booster dose of Hexavalent vaccine at 1 year

12
Q

Babies born after 1st August 2017 in the UK to hep B carrier mothers should
receive:
a) Doses of monovalent hep B vaccine at birth and 4 weeks
b) Three doses of Hexavalent vaccine at 8, 12 and 16 weeks
c) A dose of Hexavalent vaccine at 1 year
d) A dose of monovalent hep B vaccine at 1 year
e) A pre-school booster dose of monovalent vaccine at 3 years 4 months

A

Doses of monovalent hep B vaccine at birth and 4 weeks

Three doses of Hexavalent vaccine at 8, 12 and 16 weeks

A dose of monovalent hep B vaccine at 1 year

13
Q

Which of the following should NOT be given Hepatitis B vaccine:
a) Those with a confirmed anaphylactic reaction to a previous dose of Hepatitis B
vaccine
b) Immunosuppressed individuals
c) Pregnant women
d) HIV positive people
e) Premature infants

A

Those with a confirmed anaphylactic reaction to a previous dose of Hepatitis B vaccine

14
Q

The following is/are true about Human Papillomavirus (HPV) infection:

a) HPV 18 is responsible for more than 50 % of all cervical cancers in Europe
b) HPV types 6 and 11 cause the majority of genital warts
c) 90 % of new HPV infections clear within 2 years
d) Approximately 100 types of HPV infect the genital tract
e) HPV can be transmitted from mother to newborn baby

A

HPV types 6 and 11 cause the majority of genital warts

90 % of new HPV infections clear within 2 years

HPV can be transmitted from mother to new-born baby

15
Q

The following is/are true about HPV vaccines:
a) They are contraindicated in yeast allergy
b) A 2-dose schedule should be given to those who are HIV infected or known to be
immunocompromised
c) They are given intramuscularly
d) Males and females in cohorts eligible for vaccination in the National Programme
remain so until their 25th birthday
e) If a course of HPV infection is interrupted it should be repeated

A

They are given intramuscularly

Males and females in cohorts eligible for vaccination in the National Programme remain so until their 25th birthday

16
Q

The following is/are true about Gardasil:
a) It contains thiomersal
b) It contains HPV types 6,11,16 and 18
c) The minimum interval between 2 doses of Gardasil for children and adolescents
aged between 9 and below 15 years of age is 6 months
d) There is evidence on the interchangeability of Gardasil and Cervarix
e) If Gardasil is given at the same time as dTaP both vaccines can be given at the
same site

A

It contains HPV types 6,11,16 and 18

The minimum interval between 2 doses of Gardasil for children and adolescents aged between 9 and below 15 years of age is 6 months

17
Q

The following is/are true about Cervarix:

a) It will provide protection against genital warts
b) If the 3-dose course is interrupted it should be resumed but not repeated
c) It is supplied as a suspension of virus-like particles(VLPs) in a pre-filled syringe
d) The risk of local reactions is less if given intramuscularly rather than subcutaneously
e) It contains HPV types 11 and 16

A

If the 3-dose course is interrupted it should be resumed but not repeated

It is supplied as a suspension of virus-like particles(VLPs) in a pre-filled syringe

It should be given by the intramuscular route

18
Q

. In the UK, the groups recommended to receive HPV vaccine include(s):

a) Children aged 9-11 years
b) Adolescents aged 11-14 years
c) Older adolescents and adults aged 15-30 years
d) MSM aged up to and including 45 years
e) MSM aged 50 with no previous history of HPV vaccine

A

Adolescents aged 11-14 years

MSM aged up to and including 45 years

19
Q
In the UK programme the following patient groups should not be routinely
advised to receive HPV vaccine:
a) Patients with immunosuppression
b) Patients with HIV infection
c) Patients who are pregnant
d) Males aged 11-18 years
e) Females coming to the UK from overseas under the age of 18 years with an
uncertain immunisation history
A

Patients who are pregnant

Males aged 11-18 years

20
Q

Which of the following is/are true:

a) Influenza is caused by type A, B or C viruses
b) Influenza A is the usual cause of epidemics
c) Minor changes in the surface antigens of influenza A occur every year
d) “Antigenic shift” means a major change in the influenza A virus has occurred
e) The burden of influenza B disease is mostly in adults

A

Influenza is caused by type A, B or C viruses

Influenza A is the usual cause of epidemics

Minor changes in the surface antigens of influenza A occur every year

“Antigenic shift” means a major change in the influenza A virus has occurred

21
Q

Which of the following is/are true about Influenza vaccines:
a) They must be given annually
b) Current trivalent vaccines have 2 influenza A subtypes and one B subtype in them
c) Quadrivalent vaccines with an additional influenza A virus have become routinely
available
d) Most of the vaccines are prepared from viruses grown in embryonated hens’ eggs
e) They may cause influenza in some individuals

A

They must be given annually

Current trivalent vaccines have 2 influenza A subtypes and one B subtype in them

Most of the vaccines are prepared from viruses grown in embryonated hens’ eggs

22
Q

Influenza vaccine should be offered to the following:

a) The main carer of a disabled person
b) Residential care home staff
c) All the inmates of a Young Offenders Institution
d) A pregnant woman
e) A Midwife

A

The main carer of a disabled person

Residential care home staff

A pregnant woman

A midwife

23
Q

Patients with the following conditions should have seasonal influenza vaccine:

a) Class III obesity
b) Stage 2 chronic renal disease
c) Diabetes controlled by diet
d) Cystic Fibrosis
e) Severe learning disability

A

Class III obesity

Diabetes controlled by diet

Cystic Fibrosis

Severe learning disability

24
Q

The following is/are true about flu vaccine in pregnancy:
a) Influenza vaccine is contraindicated in the first trimester of pregnancy
b) The vaccine of choice for pregnant women is LAIV
c) Pregnant women are more likely to suffer side affects from the vaccine
d) Pregnant women who have received influenza vaccine are at slightly increase risk of
miscarriage
e) Influenza vaccine given to the mother may provide passive immunity to the infant in
the first few months of life

A

Influenza vaccine given to the mother may provide passive immunity to the infant in the first few months of life

25
Q

The following is/are contraindications to children receiving LAIV:

a) Lymphoma
b) Taking salicylate therapy
c) Taking inhaled corticosteroids
d) Asthma with increased wheezing in the previous 72-hours
e) HIV infection on HAART

A

Lymphoma

Taking salicylate therapy

Asthma with increased wheezing in the previous 72-hours

26
Q

Adverse reactions to inactivated flu vaccine may include:

a) Pain and swelling at the injection site
b) High grade fever
c) Myalgia
d) Shivering
e) Clinical influenza

A

Pain and swelling at the injection site

Myalgia

Shivering

27
Q

Which of the following is/are true about LAIV Fluenz Tetra®:
a) Cannot be given at the same time as other live vaccines
b) When LAIV Fluenz Tetra® is being administered, the dose should be repeated if the
patient sneezes or blows their nose
c) It may be left out of the refrigerator for a maximum of 48 hours at a temperature not
above 25°C
d) It should not be administered within 48 hours of antiviral drugs
e) It is administered as a dose of 0.2 ml into each nostril

A

It should not be administered within 48 hours of antiviral drugs

28
Q

The following is/are true about LAIV Fluenz Tetra®:
a) It contains live attenuated virus
b) It is recommended for children with egg allergy
c) It is contraindicated in patients receiving low dose inhaled corticosteroids
d) If influenza vaccine has not been received previously a 3-year-old child having LAIV
Fluenz Tetra® should receive 2 doses
e) Can be administered by health care workers who are pregnant

A

It contains live attenuated virus

Can be administered by health care workers who are pregnant

29
Q

A child aged 3 in a clinical risk group who has never received any influenza
vaccine before, should have:
a) A dose of inactivated quadrivalent vaccine, followed by a dose of LAIV 4 weeks later
b) A dose of LAIV followed by a dose of inactivated quadrivalent vaccine 4 weeks later
c) One dose of LAIV
d) Two doses of LAIV at least 4 weeks apart
e) Two doses of LAIV at least 8 weeks apart

A

Two doses of LAIV at least 4 weeks apart

30
Q

The following is/are true:
a) If not given at the same time, a 4-week interval should be observed between LAIV
and other live vaccines
b) Quadrivalent Cell Cultured Inactivated (QVIC) vaccine is an inactivated vaccine
made from influenza virus grown in chicken cells
c) Inactivated vaccines should be given using an 18-guage needle
d) Standard flu vaccines have low effectiveness against A(H3N2) in the elderly
e) Children in clinical risk groups can receive flu vaccine from 6 months of age

A

Quadrivalent Cell Cultured Inactivated (QVIC) vaccine is an inactivated vaccine made from influenza virus grown in chicken cells

Inactivated vaccines should be given using an 18-guage needle

Standard flu vaccines have low effectiveness against A(H3N2) in the elderly

Children in clinical risk groups can receive flu vaccine from 6 months of age

31
Q

Japanese encephalitis:
a) Is a tick borne viral encephalitis
b) Highest transmission rates occur during and just after dry seasons
c) Has an incubation period of 5-15 days
d) Is associated with a rate of approximately 10 % of neurological sequelae in
survivors
e) Is not transmitted from person to person

A

Has an incubation period of 5-15 days

Is not transmitted from person to person

32
Q

JE vaccine should:
a) Be given to those who are going to an endemic or epidemic area
b) Be given to laboratory staff who have potential exposure to the virus
c) Not be given to those who have had a confirmed anaphylactic or serious systemic
reaction to a previous dose of JE vaccine
d) Not be given to those who have had a confirmed anaphylactic reaction to any
component of the vaccine
e) Not be given during pregnancy and breast-feeding

A

Be given to those who are going to an endemic or epidemic area

Be given to laboratory staff who have potential exposure to the virus

Not be given to those who have had a confirmed anaphylactic or serious systemic reaction to a previous dose of JE vaccine

Not be given to those who have had a confirmed anaphylactic reaction to any component of the vaccine

33
Q

Which of the following is true about JE vaccines?
a) They contain no live organisms
b) They should be given by subcutaneous injection
c) There is currently only one licensed vaccine recommended for use in the UK -
IXIARO
d) They can be given at the same time as other travel or routine vaccines
e) They are not usually recommended in children under 1 year of age

A

They contain no live organisms

There is currently only one licensed vaccine recommended for use in the UK – IXIARO

They can be given at the same time as other travel or routine vaccines

They are not usually recommended in children under 1 year of age

34
Q

Which of the following is/are true:
a) IXIARO is licensed for individuals aged 2 months and older
b) For children aged 24 months of age the recommended vaccine schedule is 2 x 0.5
ml doses of IXIARO vaccine on days 0 and 28
c) The recommended primary schedule for IXIARO comprises 3 doses
d) Primary vaccination should be completed ideally at least one week prior to potential
exposure to JE virus
e) A rapid schedule administered at days 0 and 14 is also licensed for adults aged 18
to 65

A

For children aged 24 months of age the recommended vaccine schedule is 2 x 0.5 ml doses of IXIARO vaccine on days 0 and 28

Primary vaccination should be completed ideally at least one week prior to potential exposure to JE virus

35
Q

Recognised complications of infection with measles virus include:

a) Otitis media
b) Convulsions
c) Pneumonia
d) Constipation
e) Joint pains

A

Otitis media

Convulsions

Pneumonia

36
Q

Sub-acute sclerosing pan-encephalitis (SSPE):
a) Is a fatal late complication of measles infection
b) Occurs in every 25,000 measles infections
c) Has increased in rate since the introduction of MMR vaccine
d) The risk of developing SSPE is greater if the child has measles infection after the
age of one year
e) May take 20-30 years to develop post measles infection

A

Is a fatal late complication of measles infection

Occurs in every 25,000 measles infections

May take 20-30 years to develop post measles infection

37
Q

If a child has received a dose of MMR vaccine before the age of 12 months:
a) They need only one further dose of MMR given at the same time as the pre-school
booster immunisations
b) The child needs to receive 2 further doses of MMR vaccine given at 12-13 months
and at the same time as the pre-school boosters
c) The response to a dose given before 12 months may be suboptimal due to
persistence of maternal antibodies in the baby
d) This may increase the risk of an adverse reaction to any subsequent dose
e) It is worth checking for measles antibodies before deciding to give a further dose

A

The child needs to receive 2 further doses of MMR vaccine given at 12-13 months and at the same time as the pre-school boosters

The response to a dose given before 12 months may be suboptimal due to persistence of maternal antibodies in the baby

38
Q

Which of the following is/are true about MMR vaccine:
a) It is a live attenuated vaccine
b) It should not be given to children with autism
c) It should not be given in pregnancy
d) It is better not to give it if a person has a previous history of either measles, mumps
or rubella
e) If the vaccine course is started after the age of 18 months a child needs 2 doses
separated by 3 months

A

It is a live attenuated vaccine

It should not be given in pregnancy

39
Q

Which of the following is/are true:
a) A single dose of MMR vaccine confers protection against measles in about 80% of
individuals
b) There is a link between Guillain-Barré syndrome (GBS) and MMR vaccine
c) A mild measles-like rash may develop 3 weeks after MMR vaccine
d) Allergy to egg is not an absolute contra-indication to MMR
e) There is no evidence of measles vaccine virus being found in breast milk

A

Allergy to egg is not an absolute contra-indication to MMR

There is no evidence of measles vaccine virus being found in breast milk

40
Q

Which of the following is/are true about managing contacts of measles:
a) Advice should be sought from the local HPU or microbiologist
b) HNIG may be indicated in non-immune contacts who are pregnant,
immunocompromised or under 9 months of age
c) In susceptible immunocompetent contacts in whom MMR is not contra-indicated a
dose of MMR may protect them if given within 3 days of exposure
d) Where HNIG is given, an interval of at least 3 months must be allowed before
subsequent MMR immunisation
e) Measles infection in pregnancy can lead to congenital malformation

A

Advice should be sought from the local HPU or microbiologist

HNIG may be indicated in non-immune contacts who are pregnant, immunocompromised or under 9 months of age

In susceptible immunocompetent contacts in whom MMR is not contra-indicated a dose of MMR may protect them if given within 3 days of exposure

Where HNIG is given, an interval of at least 3 months must be allowed before subsequent MMR immunisation

41
Q

A diagnosis of meningococcal infection requires the following to be present:

a) Headache
b) Neck stiffness
c) Photophobia
d) Drowsiness
e) Pyrexia

A

None of the answers listed are required to give a diagnosis of meningococcal infection, although any of the symptoms may be present

42
Q

Meningococcal infection in young infants:

a) Rarely presents with an insidious onset
b) Will usually present with the classical signs of meningitis
c) Should be considered if the child has a raised anterior fontanelle, if still patent
d) Is likely to be present in an apyrexial child
e) Should be considered where a child is irritable

A

Should be considered if the child has a raised anterior fontanelle, if still patent

Should be considered where a child is irritable

43
Q
  1. Meningococci:
    a) Are most often harmless commensals colonising the nasopharynx
    b) Are carried by about a quarter of adolescents, who show no signs of disease
    c) Are transmitted by aerosol
    d) Are usually transmitted with minimal contact
    e) Cause infection most frequently in teenagers
A

Are most often harmless commensals colonising the nasopharynx

Are carried by about a quarter of adolescents, who show no signs of disease

Are transmitted by aerosol

44
Q

Meningococcal C conjugate (MenC) vaccine:
a) Was introduced to the UK routine immunisation programme in 1999
b) The first dose is given in the UK primary vaccination schedule to children at 3
months
c) Should be offered as a single dose to anyone over the age of 10 years who has not
completed the primary childhood schedule up to the age of 50
d) Is given as Hib/Men C vaccine between 12 and 13 months of age and as a
component of ACWY vaccine in adolescence in the UK primary vaccination schedule
e) Children over the age of 1 and under the age of 10 who have not received any Men
C vaccine should be offered a single dose of Hib/Men C vaccine

A

Was introduced to the UK routine immunisation programme in 1999

Is given as Hib/Men C vaccine between 12 and 13 months of age and as a component of ACWY vaccine in adolescence in the UK primary vaccination schedule

Children over the age of 1 and under the age of 10 who have not received any Men C vaccine should be offered a single dose of Hib/Men C vaccine

45
Q

Which of the following is/are true about children and adults with asplenia and
splenic dysfunction:
a) Children under one year of age should receive 2 doses of Men ACWY vaccine one
month apart
b) Children presenting over 2 years of age and under 10 should be given one dose of
Hib/Men C vaccine, one dose of PPV23 and one dose of Men ACWY conjugate
vaccine 1 year later
c) Adults who develop splenic dysfunction should be offered Men B vaccine
d) If travelling to a country at increased risk of A, W135 or Y disease children under 5
should be offered Men ACWY polysaccharide vaccine
e) Conjugate Men ACWY vaccine gives a poorer response than polysaccharide Men
ACWY vaccine

A

Children under one year of age should receive 2 doses of Men ACWY vaccine one month apart

Adults who develop splenic dysfunction should be offered Men B vaccine

46
Q

Meningococcal vaccines are contra-indicated in the following:

a) Pregnant women
b) HIV positive people
c) Other people with severe immuno-compromising conditions
d) Premature infants
e) Breast feeding mothers

A

There are no correct answers, all the following could receive meningococcal vaccine

47
Q

Which of the following is/are true quadrivalent ACWY conjugate vaccines:

a) They are live vaccines
b) They are conjugated to other CRM 197 or tetanus toxoid carrier proteins
c) They can provide limited cross protection against group B meningococcal disease
d) They provide longer lasting immunity than polysaccharide meningococcal vaccine
e) They are given intramuscularly

A

They are conjugated to other CRM 197 or tetanus toxoid carrier proteins

They provide longer lasting immunity than polysaccharide meningococcal vaccine

They are given intramuscularly

48
Q

Which of the following is/are recognised adverse reactions to meningococcal
vaccines:
a) Fever > 39.5°C with Hib/Men C conjugate vaccine
b) Atopic dermatitis occurring after MenC/Hib combined vaccine
c) Impaired sleep following MenC conjugate vaccine
d) Diarrhoea in infants and toddlers following MenC vaccine
e) Fever > 38°C and irritability in children under 10 with 4CMenB vaccine Bexsero

A

Fever > 39.5°C with Hib/Men C conjugate vaccine

Atopic dermatitis occurring after Men C/Hib combined vaccine

Impaired sleep following Men C conjugate vaccine

Diarrhoea in infants and toddlers following MenC vaccine

Fever > 38°C and irritability in children under 10 with 4CMenB vaccine Bexsero

49
Q

The following is/are true about quadrivalent ACWY vaccines for travel:
a) Immunisation with ACWY vaccine is recommended for long stay visitors to subSaharan Africa
b) Children under 1 need one dose of Menveo®
c) Children aged between 5 and 10 need 2 doses of Menveo® or Nimenrix®
d) A dose of 4CMenB vaccine should routinely be given in conjunction with the ACWY
vaccine to those travelling abroad
e) If an infant has already had Men C vaccination, then Men ACWY should also be
given

A

Immunisation with ACWY vaccine is recommended for long stay visitors to sub-Saharan Africa

If an infant has already had Men C vaccination, then Men ACWY should also be given

50
Q

The following is/are true about 4C Men B protein vaccine (Bexsero®):
a) Bexsero® may protect up to 98% of circulating Men B strains in England and Wales
b) Bexsero® may also protect against infection by other capsular groups of
meningococcus
c) Is currently recommended for all household contacts of an index case of invasive
group B meningococcal disease
d) Is licensed for use from 2 months of age
e) Is made from one N. meningitidis protein

A

Bexsero® may also protect against infection by other capsular groups of meningococcus

51
Q

The following is/are true about 4C Men B protein vaccine (Bexsero®):
a) It is supplied as a vial of white powder with a separate diluent
b) In the routine immunisation schedule is given at 2 and 4 months with a booster at 12
– 13 months
c) In the routine immunisation schedule is given at 2, 3 and 4 months
d) It should be offered as a single dose to students attending university for the first time
e) Is now routinely recommended for individuals who are travelling or going to reside
abroad

A

In the routine immunisation schedule is given at 2 and 4 months with a booster at 12 – 13 months

52
Q

Regarding the 4C Men B protein vaccine (Bexsero®):
a) Post vaccination fever peaks at around 2 hours and has usually gone by 24 hours
after vaccination
b) Three doses of paracetamol given prophylactically at the time of vaccination then at
4-6 hourly intervals reduces the fever
c) Ibuprofen has been found to be as effective as paracetamol in reducing the fever
d) The immunogenicity of other routine vaccines in infants co-administered with 4C
MenB is not affected by giving paracetamol
e) Fever of ≥40°C in a child following a dose of Bexsero® is a contraindication to the
child receiving a further dose of the vaccine

A

Three doses of paracetamol given prophylactically at the time of vaccination then at 4 – 6 hourly intervals reduces the fever

The immunogenicity of other routine vaccines in infants co-administered with 4C MenB is not affected by giving paracetamol